Update on a new subgroup 3 and failure rates for HeartWare™ Ventricular Assist Device (HVAD™) System

Update on a new subgroup 3 and failure rates for HeartWare™ Ventricular Assist Device (HVAD™) System

A Dear Healthcare Professional Letter has been issued by Medtronic International Limited, as a follow-up to their earlier communications in January 2021, July 2021, March 2022 and October 2022, to inform healthcare professionals on the following:

a) An additional subgroup population, subgroup 3, has been identified which may experience a delay to restart or failure to restart the pump at a higher rate than the general HeartWare™ Ventricular Assist Device (HVAD™) population

b) Current failure rates associated with a failure or delay to restart pump event

c) Reiterate existing patient management recommendations which will also apply to subgroup 3

Healthcare professionals are advised to follow the patient management recommendations and to prepare an individualized care plan for each subgroup patient. Please refer to the letter for details.

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of these letters can be found in the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://hpp.moh.gov.sg and follow the procedures below to access the MOH Alert system.

Step 1: Select your profession under ‘For Healthcare Professionals’.

Step 2: Click on ‘Useful links’.

Step 3: Click on ‘MOH Alert’ and log in via Singpass.

Step 4: Click on ‘Drug Alerts’ or ‘Med Device Alerts’ to view the DHCPLs.